检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]海南省农垦三亚医院眼科,海南三亚572000
出 处:《中华眼外伤职业眼病杂志》2014年第2期143-145,共3页Chinese Journal of Ocular Trauma and Occupational Eye Disease
基 金:海南省三亚市医疗卫生科技创新项目(2012年,YW1202)
摘 要:目的 探讨小梁切除术联合可松解缝线及抗代谢药物对原发性闭角型青光眼(PACG)的疗效.方法 对小梁切除术联合可松解缝线及抗代谢药物的PACG 146例(180眼)进行回顾性研究,分析术后眼压控制情况、滤过泡形态及并发症.结果 所有180眼中,152眼(84.4%)不用降眼压药物情况下眼压在10~21 mmHg:26眼(14.4%)加用局部降眼压药物,眼压控制在10~21 mm-Hg:2眼(1.1%)眼压失控,分别于术后3个月和5个月行睫状体冷凝治疗.未出现浅前房、低眼压或滤过泡相关并发症.结论 小梁切除术联合可松解缝线及抗代谢药物治疗PACG能较好控制术后眼压并避免术后早期浅前房、低眼压等并发症,减少滤过道瘢痕化的发生.Objective To discuss clinical effect of the compound trabeculectomy combined with releasable suture and anti-metabolite medicines in primary angle-closure glaucoma(PACG).Methods The postoperative condition of intraocular pressure (IOP),bleb formation and complications were recorded through a retrospective study on 180 eyes of 146 cases of PACG who underwent compound trabeculectomy combined with the releasable suture and anti-metabolite medication.Results There were 152 eyes (84.4%) with functional filtering bleb,and their postoperative IOP were 10 ~21mmHg without using ocular hypotensive agents ;26 eyes (14.4%) with the tendency of forming cicatricial nonfunctional filtering bleb and their postoperative IOP were 10 ~ 21mmHg with using local ocular hypotensive agents; 2 eyes (1.1%)with not obvious filtering bleb and uncontrollable IOP,cyclocryotherapy were performed postoperatively in 3 months and 5 months.No shallow anterior chamber,ocular hypotension or filtering bleb related complications appeared.Conclusion The compound trabeculectomy combined with releasable suture and anti-metabolite medication in primary angle-closure glaucoma can control postoperative IOP preferably,avoid shallow anterior chamber and ocular hypotension complications and improve the healing condition obviously.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:3.147.77.120